Search results
ASCO: Replacing chemotherapy with ADCs? AbbVie rebuilds next-gen assets after Rova-T flop
FierceBiotech· 1 day agoA new trend has emerged at this year’s American Society of Clinical Oncology conference: the...
Lung cancer wonder drug hailed as study shows 'off the chart' survival benefit
Daily Express· 5 days agoResults from a trial of daily pill lorlatinib were described as "unprecedented".
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters via AOL· 5 days ago(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder...
Newswise Expert | Puneeth Iyengar, UT Southwestern Medical Center
Newswise· 14 hours agoBriefly, Puneeth Iyengar joined the UT Southwestern Medical Center in Dallas, TX USA in the summer of 2010 and is currently an Assistant Professor of Radiation Oncology, with a professional ...
Pfizer drug extends life for people with rare form of lung cancer
AFP via Yahoo News· 5 days agoA Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival...
Does Palliative Care via Telehealth Work in Advanced Cancer?
Medscape· 2 days agoEarly palliative care can be delivered successfully and efficiently using telehealth in patients...
Trial reveals benefits of 'stepped' palliative care for patients with advanced lung cancer
Medical Xpress· 2 days agoA new study led by investigators from Mass General Cancer Center reveals the effectiveness of more...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 3 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 5 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 2 days agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result ...